| scholarly article | Q13442814 |
| editorial | Q871232 |
| P6179 | Dimensions Publication ID | 1035476303 |
| P356 | DOI | 10.1097/GIM.0B013E3181F9AD55 |
| P698 | PubMed publication ID | 20975567 |
| P5875 | ResearchGate publication ID | 47544959 |
| P50 | author | Muin J. Khoury | Q64746271 |
| Ralph J. Coates | Q124654554 | ||
| P2093 | author name string | James P Evans | |
| P2860 | cites work | Letting the genome out of the bottle--will we get our wish? | Q28264215 |
| Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement | Q28265041 | ||
| The rules remain the same for genomic medicine: the case against "reverse genetic exceptionalism". | Q34121303 | ||
| Screening for hemochromatosis: recommendation statement | Q34552980 | ||
| Shared decision making about screening and chemoprevention. a suggested approach from the U.S. Preventive Services Task Force | Q35618841 | ||
| Promoting informed decisions about cancer screening in communities and healthcare systems | Q35618847 | ||
| Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors | Q37037058 | ||
| The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group | Q37277889 | ||
| Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? | Q37345971 | ||
| Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives | Q37345978 | ||
| Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? | Q37345983 | ||
| Comparative effectiveness research and genomic medicine: an evolving partnership for 21st century medicine | Q37596937 | ||
| The evolving role of prevention in health care: contributions of the U.S. Preventive Services Task Force | Q40713088 | ||
| The evidence dilemma in genomic medicine. | Q50769689 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 680-683 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | Evidence-based classification of recommendations on use of genomic tests in clinical practice: dealing with insufficient evidence | |
| P478 | volume | 12 |
| Q31000681 | A conceptual model for translating omic data into clinical action |
| Q57263696 | A critical view of the general public’s awareness and physicians’ opinion of the trends and potential pitfalls of genetic testing in Greece |
| Q50137319 | Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation |
| Q37086591 | Adopting orphans: comprehensive genetic testing of Mendelian diseases of childhood by next-generation sequencing |
| Q57697028 | Are health technology assessments of pharmacogenetic tests feasible? A case study ofCYP2D6testing in the treatment of breast cancer with tamoxifen |
| Q48503018 | Assessing the readiness of precision medicine interoperabilty: An exploratory study of the National Institutes of Health genetic testing registry |
| Q94595312 | Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study |
| Q27022338 | Collaborative cancer epidemiology in the 21st century: the model of cancer consortia |
| Q38424242 | Current priorities for public health practice in addressing the role of human genomics in improving population health |
| Q46486965 | EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS. |
| Q34451291 | Evaluating genomic tests from bench to bedside: a practical framework |
| Q36318310 | Family history intake: a challenge to personalized approaches in health promotion and disease prevention |
| Q64107539 | Healthcare System Priorities for Successful Integration of Genomics: An Australian Focus |
| Q50106856 | How is genetic testing evaluated? A systematic review of the literature. |
| Q39234236 | Implementation of an electronic genomic and family health history tool in primary prenatal care. |
| Q28729140 | Implications of Internet availability of genomic information for public health practice |
| Q38239811 | Managing the ethical challenges of next-generation sequencing in genomic medicine |
| Q92526168 | Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health |
| Q37716310 | Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening. |
| Q34938911 | Personalizing health care: feasibility and future implications |
| Q38248763 | Pharmacogenetic approaches in the treatment of alcohol use disorders: addressing clinical utility and implementation thresholds |
| Q34343365 | Pharmacogenetics in clinical practice: how far have we come and where are we going? |
| Q33910107 | Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. |
| Q34280025 | Pharmacogenomics and personalized medicine in neuropsychiatry |
| Q36541027 | Prediction of Cancer Prevention: From Mammogram Screening to Identification of BRCA1/2 Mutation Carriers in Underserved Populations |
| Q36398661 | Prioritizing genomic applications for action by level of evidence: a horizon-scanning method |
| Q44981166 | Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy |
| Q38129303 | Storing and interpreting genomic information in widely deployed electronic health record systems |
| Q64118275 | The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine |
| Q39560565 | The effects of learning about one's own genetic susceptibility to alcoholism: a randomized experiment. |
| Q36157315 | When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives |
| Q37507366 | Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations |
| Q26798243 | Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makers |
| Q35627358 | You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative |
Search more.